This is a working overview of bioavailability, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-07-20 and is reviewed periodically as new material appears.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small-molecule ligand; not a hormone or peptide |
| Molecular formula | C20H24ClN3O4S | Reported for the free base |
| CAS Registry Number | 1379686-30-2 | Unique chemical identifier |
| Common synonyms | SR9009; stenabolic | Stenabolic is informal and not an official name |
| Reported targets | REV-ERBα and REV-ERBβ | Nuclear receptors linked to circadian and metabolic regulation |
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
After a memorable 90th birthday, at which she was surrounded by her now vast family, Zita's habitually-robust health began to fail. She developed inoperable cataracts in both eyes. Her last major family gathering took place at Zizers, in 1987, when her children and grandchildren joined in celebrating her 95th birthday. While visiting her daughter, in summer 1988, she developed pneumonia and spent most of the autumn and winter bedridden. Finally, she called Otto in early March 1989 and told him she was dying. He and the rest of the family travelled to her bedside and took turns keeping her company until she died in the early hours of 14 March 1989. She was 96 years old, and was the last surviving child of Robert, Duke of Parma from both his marriages. Her funeral was held in Vienna on 1 April. The government allowed it to take place on Austrian soil if the cost was borne by the Habsburgs themselves. Zita's body was carried to the Imperial Crypt under Capuchin Church in the same funeral coach she had walked behind during the funeral of Emperor Franz Joseph in 1916. It was attended by over 200 members of the Habsburg and Bourbon-Parma families, and the service had 6,000 attendees including leading politicians, state officials and international representatives, including a representative of Pope John Paul II. Following an ancient custom, the Empress had asked that her heart, which was placed in an urn, stay behind at Muri Abbey, in Switzerland, where the Emperor's heart had rested for decades.
There are also potential environmental effects from the tools needed for mining these hydrothermal vent ecosystems, including noise pollution and anthropogenic light. Hydrothermal vent system mining would require the use of both submerged mining tools on the seafloor, including remotely operated underwater vehicles (ROVs), as well as surface support vessels on the ocean surface. Inevitably, through the operation of these machines, some level of noise will be created, which presents a problem for hydrothermal vent organisms because, as they are up to 12,000 feet below the surface of the ocean, they experience very little sound. As a result of this, these organisms have evolved to have highly sensitive hearing organs, so if there is a sudden increase in noise, such as that created by mining machinery, there is potential to damage these auditory organs and harm the vent organisms. It is also important to consider that many studies have been able to show that a large percent of benthic organisms communicate using very low-frequency sounds; therefore, increasing ambient noise levels on the seafloor could potentially mask communication between the organisms and alter behavioral patterns. Similar to how deep-sea SMS mining tools create noise pollution, they also create anthropogenic light sources on the seafloor (from mining tools) and the ocean surface (from surface support vessels). Organisms at these hydrothermal vent systems are in the aphotic zone of the ocean and have adapted to very low light conditions.
Raleigh's industrial base includes financial services, electrical, medical, electronic and telecommunications equipment, clothing and apparel, food processing, paper products, and pharmaceuticals. Raleigh is part of North Carolina's Research Triangle, one of the country's largest and most successful research parks, and a major center in the United States for high-tech and biotech research, as well as advanced textile development. The city is a major retail shipping point for eastern North Carolina and a wholesale distributing point for the grocery industry. The healthcare and pharmaceutical industry has experienced major growth in recent years with many companies based in Raleigh including PRA Health Sciences, Chiesi USA (subsidiary of Chiesi Farmaceutici), formerly Mallinckrodt prior to tax inversion to Ireland, MAKO Surgical Corp., Metabolon, Inc., TearScience, and American Board of Anesthesiology. Companies based in Raleigh include Advance Auto Parts, Bandwidth, Building Materials Holding Corporation, Capitol Broadcasting Company, First Citizens BancShares, Golden Corral, Japan Tobacco International, Martin Marietta Materials, PRA Health Sciences, Red Hat, Vontier, Waste Industries, and Lulu. Social Blade, a website that tracks social media statistics and analytics, and Temple Run developer Imangi Studios are based in Raleigh. The North Carolina Air National Guard, a unit of the Air National Guard, is also headquartered in Raleigh. In April 2014 Steven P. Rosenthal of Northland Investment Corp. referred to Raleigh as "a real concentration of brain power.
Humans use scorpions both practically, for medicine, food, and pets, and symbolically, whether as gods, to ward off harm, or to associate a product or business with the evident power of the small but deadly animal.
Sources: en.wikipedia.org
== Expression == In insects, CSPs are found throughout the whole insect development process from eggs and larvae to nymphal and adult stages [4, 16-19]. In locusts, they are mainly expressed in the antennae, tarsi and legs, and found to be associated with phase change [3-4, 20-22]. CSPs are not the apanage of insects. They are also expressed in many various organisms such as crustacean, shrimp and many other arthropod species [23]. However, they are not specific to the arthropod kingdom. They are also expressed at the level of the bacterial superkingdom, demonstrating their existence not only in eukaryotes, but also in prokaryote organisms [23-24]. Prokaryote CSPs are twins or identical twins to insect CSPs [24]. They have been reported from bacterial species such as coccobacillus Acinetobacter baumannii, Macrococcus/Staphylococcus caseolyticus, the filamentous actinomycete Kitasatospora griseola, an Actinobacteria genus in the family Streptomycetaceae, and Escherichia coli (E. coli) which are known as common bacteria from the digestive tract, main prokaryotic secondary metabolites, opportunistic multi-drug resistant pathogens, high positive cytochrome c oxidase reactions, and symbionts of multiple insect species [24]. Their existence has been mentioned in plants, but this still needs to be demonstrated experimentally [25-26]. CSPs can be extracted from wasp venom [27]. In moths, nearly all CSPs are expressed in the female pheromone gland [9-14].
) A measure of the solubility of an ionic solute, expressed as the arithmetic product of the concentrations of its ions in a fully saturated solution, with respect to the solute's particular dissociation equilibria and the particular ions present. For a dissociation equilibrium
, respectively. Their ratio is not equal to the equilibrium constant, which implies that thermodynamics does not constrain the ratio of the maximal rates. This explains that enzymes can be much "better catalysts" (in terms of maximal rates) in one particular direction of the reaction. One can also derive the two Michaelis constants
Protons and neutrons are arranged in shells, just like electrons, and so a closed shell can significantly increase stability: the known superheavy nuclei exist because of such a shell closure, probably at around 114–126 protons and 184 neutrons. They are probably close to a predicted island of stability, where superheavy nuclides should be more long-lived than otherwise expected: predictions for the longest-lived nuclides on the island range from microseconds to millions of years. It should nonetheless be noted that these are essentially extrapolations into an unknown part of the chart of nuclides, and systematic model uncertainties need to be taken into account. As the closed shells are passed, the stabilizing effect should vanish. Thus, superheavy nuclides with more than 184 neutrons are expected to have much shorter lifetimes, spontaneously fissioning within 10−15 seconds. If this is so, then it would not make sense to consider them chemical elements: IUPAC/IUPAP theorizes and recommends an element to exist only if the nucleus lives longer than 10−14 seconds, the time needed for it to gather an electron cloud. Nonetheless, theoretical estimates of half-lives are very model-dependent, ranging over many orders of magnitude. The extreme repulsion between protons is predicted to result in exotic nuclear topologies, with bubbles, rings, and tori expected: this further complicates extrapolation. It is not clear if any further-out shell closures exist, due to an expected smearing out of distinct nuclear shells (as is already expected for the electron shells at oganesson).
Fewer than half of the planned centers were created, and new methods did not fully replace the old approaches to carry out its full capacity of treating power. Besides, the community helping system was not fully established to support the patients' housing, vocational opportunities, income supports, and other benefits. Many patients returned to welfare and criminal justice institutions, and more became homeless. The movement of deinstitutionalization was facing great challenges. After realizing that simply changing the location of mental health care from the state hospitals to nursing houses was insufficient to implement the idea of deinstitutionalization, the National Institute of Mental Health (NIMH) in 1975 created the Community Support Program (CSP) to provide funds for communities to set up a comprehensive mental health service and supports to help the mentally ill patients integrate successfully in the society. The program stressed the importance of other supports in addition to medical care, including housing, living expenses, employment, transportation, and education; and set up new national priority for people with serious mental disorders. In addition, the Congress enacted the Mental Health Systems Act of 1980 to prioritize the service to the mentally ill and emphasize the expansion of services beyond just clinical care alone. Later in the 1980s, under the influence from the Congress and the Supreme Court, many programs started to help the patients regain their benefits.
Sources: en.wikipedia.org
Drug expiration is the date after which a drug might not be suitable for use as manufactured. Consumers can determine the shelf life for a drug by checking its pharmaceutical packaging for an expiration date. Drugs which are past their shelf life can decompose and either be ineffective or even harmful. Standard advice from drug manufacturers and some health organizations is to dispose of drugs after the expiration date printed on the packaging. However, the published expiration date is not an absolute indication that a drug has spoiled. Consumers and organizations sometimes use expired drugs for medical treatment either as a cost saving measure or because they otherwise cannot access drugs which are not expired. Medical authorities find it difficult to discuss when consumers can safely use drugs after the printed expiration date because it is difficult to obtain clear information.
=== Chemical symbol === Deuterium is often represented by the chemical symbol D. Since it is an isotope of hydrogen with mass number 2, it is also represented by 2H. IUPAC allows both D and 2H, though 2H is preferred. A distinct chemical symbol is used for convenience because of the isotope's common use in various scientific processes. Also, its large mass difference with protium (1H) confers non-negligible chemical differences with 1H compounds. Deuterium has a mass of 2.014102 Da, about twice the mean hydrogen atomic weight of 1.007947 Da, or twice protium's mass of 1.007825 Da. The isotope weight ratios within other elements are largely insignificant in this regard.
=== Mechanism of action === Fomepizole is a competitive inhibitor of the enzyme alcohol dehydrogenase, found in the liver. This enzyme plays a key role in the metabolism of ethylene glycol, and of methanol.
Denmark has low electricity costs (including costs for cleaner energy) in the EU, but general taxes (11.7 billion DKK in 2015) make the electricity price for households the highest in Europe. As of 2015, Denmark has no environmental tax on electricity. Denmark is a long-time leader in wind energy and a prominent exporter of Vestas and Siemens wind turbines, and in 2019 Denmark's exports of wind-turbine technology and services amounted to €8.9 billion. It has integrated fluctuating and less predictable energy sources such as wind power into the grid. Wind produced the equivalent of 43% of Denmark's total electricity consumption in 2017. The share of total energy production is smaller: In 2015, wind accounted for 5% of total Danish energy production. Energinet.dk is the Danish national transmission system operator for electricity and natural gas. The electricity grids of western Denmark and eastern Denmark were not connected until 2010 when the 600MW Great Belt Power Link went into operation. Cogeneration plants are the norm in Denmark, usually with district heating which serves almost 1.9 million households (January 1, 2025), 68% of all households. Waste-to-energy incinerators produce mostly heating and hot water. Vestforbrænding in Glostrup Municipality operates Denmark's largest incinerator, a cogeneration plant which supplies electricity to 80,000 households and heating equivalent to the consumption in 63,000 households (2016). Amager Bakke is an example of a new incinerator.
=== Ion-exchange and pH-Zone-refining === In an conventional CCC experiment the biphasic solvent system is pre-equilibrated before the instrument is filled with the stationary phase and equilibrated with the mobile phase. An ion-exchange mode has been created by modifying both of the phases after pre-equilibration. Generally, an ionic displacer (or eluter) is added to mobile phase and an ionic retainer is added to the stationary phase. For example, the aqueous mobile phase may contain NaI as a displacer and the organic stationary phase may be modified with the quaternary ammonium salt called Aliquat 336 as a retainer. The mode known a pH-zone-refining is a type of ion-exchange mode that utilizes acids and/or bases as solvent modifiers. Typically, the analytes are eluted in an order determined by their pKa values. For example, 6 oxindole alkaloids were isolated from a 4.5g sample of Gelsemium elegans stem extract with a biphasic solvent system composed of hexane–ethyl acetate–methanol–water (3:7:1:9, v/v) where 10 mM triethylamine (TEA) was added to the upper organic stationary phase as a retainer and 10 mM hydrochloric acid (HCl) to the aqueous mobile phase as an eluter. Ion-exchange modes such as pH-zone-refining have tremendous potential because high sample loads can be achieved without sacrificing separation power. It works best with ionizable compounds such as nitrogen containing alkaloids or carboxylic acid containing fatty acids.
Sources: en.wikipedia.org
SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.
No. It has no approved medical indication, and human safety and efficacy data are limited. It appears in research chemical markets and is banned by some sports authorities.
Natural ligands include heme and certain metabolites; SR9009 is a synthetic small molecule with higher potency and selectivity in some assays. Its effects depend on cell type and timing. It is not a naturally occurring compound.
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.